CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|||||
| Revenue | |||||||
| Total Revenue | $ 743,155 | $ 640,256 | $ 478,498 | ||||
| Costs and Expenses | |||||||
| Cost of revenue | 37,830 | 30,404 | 25,197 | ||||
| Traffic acquisition costs and media buy | 432,943 | 372,601 | 288,018 | ||||
| Research and development | 33,066 | 34,424 | 35,348 | ||||
| Selling and marketing | 57,991 | 56,014 | 53,209 | ||||
| General and administrative | 31,799 | 27,629 | [1] | 23,179 | [1] | ||
| Change In Fair Value Of Contingent Consideration | 18,694 | (3,816) | [1] | (2,246) | [1] | ||
| Depreciation and amortization | 14,092 | 13,838 | 9,897 | ||||
| Total Costs and Expenses | 626,415 | 531,094 | 432,602 | ||||
| Income from Operations | 116,740 | 109,162 | 45,896 | ||||
| Financial income (expense), net | 20,951 | 4,502 | (581) | ||||
| Income before Taxes on Income | 137,691 | 113,664 | 45,315 | ||||
| Taxes on income | 20,278 | 14,439 | 6,609 | ||||
| Net Income | $ 117,413 | $ 99,225 | $ 38,706 | ||||
| Net Earnings per Share - Basic: | $ 2.49 | $ 2.21 | $ 1.13 | ||||
| Net Earnings per Share - Diluted: | $ 2.34 | $ 2.06 | $ 1.02 | ||||
| Weighted average number of shares - Basic: | 47,128,232 | 44,871,149 | 34,397,134 | ||||
| Weighted average number of shares - Diluted: | 50,073,985 | 48,071,638 | 37,829,725 | ||||
| Display Advertising [Member] | |||||||
| Revenue | |||||||
| Total Revenue | $ 398,244 | $ 360,690 | $ 265,323 | ||||
| Search Advertising [Member] | |||||||
| Revenue | |||||||
| Total Revenue | $ 344,911 | $ 279,566 | $ 213,175 | ||||
| |||||||
| X | ||||||||||
- Definition The amounts represents change in fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Cost of revenue expenses. No definition available.
|
| X | ||||||||||
- Definition Represents the traffic acquisition and media buy costs deducted from gross sales to derive net sales. No definition available.
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|